Annual Revenue
N/A
December 31, 2023
Summary
- PTIX annual revenue is not available.
Performance
PTIX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- PTIX quarterly revenue is not available.
Performance
PTIX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- PTIX TTM revenue is not available.
Performance
PTIX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
PTIX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
PTIX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Protagenic Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | $85.00 K(-99.8%) | - | - |
| Sep 2011 | - | $12.33 M(+96.6%) | $33.49 M(+10.4%) |
| Jun 2011 | - | $6.27 M(-11.1%) | $30.34 M(-13.0%) |
| Mar 2011 | - | $7.05 M(-10.0%) | $34.88 M(-12.9%) |
| Dec 2010 | $40.03 M(-42.1%) | $7.84 M(-14.6%) | $40.03 M(-12.7%) |
| Sep 2010 | - | $9.18 M(-15.1%) | $45.85 M(-11.1%) |
| Jun 2010 | - | $10.81 M(-11.4%) | $51.55 M(-10.7%) |
| Mar 2010 | - | $12.20 M(-10.7%) | $57.74 M(-16.4%) |
| Dec 2009 | $69.09 M(-39.3%) | $13.66 M(-8.2%) | $69.09 M(-11.8%) |
| Sep 2009 | - | $14.87 M(-12.6%) | $78.31 M(-16.9%) |
| Jun 2009 | - | $17.01 M(-27.8%) | $94.25 M(-13.3%) |
| Mar 2009 | - | $23.55 M(+2.9%) | $108.69 M(-4.6%) |
| Dec 2008 | $113.88 M(+207.9%) | $22.88 M(-25.8%) | $113.88 M(+8.5%) |
| Sep 2008 | - | $30.82 M(-2.0%) | $104.96 M(+24.0%) |
| Jun 2008 | - | $31.45 M(+9.4%) | $84.64 M(+40.9%) |
| Mar 2008 | - | $28.74 M(+106.0%) | $60.08 M(+62.5%) |
| Dec 2007 | $36.98 M(+97.5%) | $13.95 M(+32.9%) | $36.98 M(+60.6%) |
| Sep 2007 | - | $10.49 M(+52.2%) | $23.03 M(+83.7%) |
| Jun 2007 | - | $6.89 M(+22.2%) | $12.54 M(+122.2%) |
| Mar 2007 | - | $5.64 M(+1.1%) | $5.64 M(+1.1%) |
| Dec 2006 | $18.72 M | - | - |
| Apr 2006 | - | $5.58 M(+63.7%) | $5.58 M(-58.8%) |
| Apr 2003 | - | $3.41 M(+34.4%) | $13.56 M(-7.8%) |
| Jan 2003 | - | $2.54 M(-23.7%) | $14.70 M(-10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2002 | - | $3.32 M(-22.6%) | $16.50 M(-11.2%) |
| Jul 2002 | $18.57 M(-14.1%) | $4.29 M(-5.7%) | $18.57 M(-6.9%) |
| Apr 2002 | - | $4.55 M(+5.1%) | $19.95 M(-3.6%) |
| Jan 2002 | - | $4.33 M(-19.8%) | $20.69 M(-4.8%) |
| Oct 2001 | - | $5.40 M(-4.8%) | $21.74 M(+0.5%) |
| Jul 2001 | $21.63 M(+1.1%) | $5.67 M(+7.3%) | $21.63 M(-0.6%) |
| Apr 2001 | - | $5.29 M(-1.8%) | $21.76 M(+1.2%) |
| Jan 2001 | - | $5.38 M(+1.9%) | $21.50 M(+0.4%) |
| Oct 2000 | - | $5.29 M(-9.0%) | $21.41 M(+0.2%) |
| Jul 2000 | $21.39 M(+14.0%) | $5.81 M(+15.6%) | $21.36 M(+2.7%) |
| Apr 2000 | - | $5.02 M(-5.2%) | $20.81 M(+4.2%) |
| Jan 2000 | - | $5.30 M(+1.2%) | $19.97 M(+4.2%) |
| Oct 1999 | - | $5.24 M(-0.3%) | $19.17 M(+2.3%) |
| Jul 1999 | $18.76 M(+20.2%) | $5.25 M(+25.4%) | $18.74 M(+7.7%) |
| Apr 1999 | - | $4.19 M(-7.0%) | $17.40 M(-1.8%) |
| Jan 1999 | - | $4.50 M(-6.3%) | $17.71 M(+7.9%) |
| Oct 1998 | - | $4.80 M(+22.6%) | $16.41 M(+5.1%) |
| Jul 1998 | $15.62 M(+23.9%) | $3.92 M(-13.0%) | $15.62 M(+8.4%) |
| Apr 1998 | - | $4.50 M(+40.6%) | $14.40 M(+5.9%) |
| Jan 1998 | - | $3.20 M(-20.0%) | $13.60 M(+2.3%) |
| Oct 1997 | - | $4.00 M(+48.1%) | $13.30 M(+5.6%) |
| Jul 1997 | $12.60 M | $2.70 M(-27.0%) | $12.60 M(+27.3%) |
| Apr 1997 | - | $3.70 M(+27.6%) | $9.90 M(+59.7%) |
| Jan 1997 | - | $2.90 M(-12.1%) | $6.20 M(+87.9%) |
| Oct 1996 | - | $3.30 M | $3.30 M |
FAQ
- What is the all time high annual revenue for Protagenic Therapeutics?
- What is the all time high quarterly revenue for Protagenic Therapeutics?
- What is the all time high TTM revenue for Protagenic Therapeutics?
What is the all time high annual revenue for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual revenue is $113.88 M
What is the all time high quarterly revenue for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly revenue is $31.45 M
What is the all time high TTM revenue for Protagenic Therapeutics?
Protagenic Therapeutics all-time high TTM revenue is $113.88 M